Explore our market-ready base formulations, custom nutrient complexes, and advanced manufacturing solutions tailored for global brands.
The global dietary supplement landscape is undergoing a paradigm shift driven by consumer demand for measurable biological efficacy. Traditional oral nutraceutical formats—such as standard compressed tablets, unencapsulated botanical powders, and simple oil softgels—frequently encounter biological bottlenecks including stomach acid degradation, rapid enzymatic breakdown in the digestive tract, and poor intestinal membrane permeability. Consequently, active ingredients often exhibit minimal oral bioavailability, leaving up to 80% to 90% of the ingested nutrient unabsorbed.
As a leading OEM/ODM Liposomal Supplements Factory & Supplier, our contract development and manufacturing organization (CDMO) addresses these pharmacokinetic limitations through advanced lipid nanoparticle engineering. Liposomal technology encapsulates hydrophilic (water-soluble) and lipophilic (fat-soluble) bioactive compounds within a protective phospholipid bilayer structure identical to human cellular membranes. This nanocarrier mechanism shields sensitive molecules from gastric hydrolysis, bypasses first-pass hepatic metabolism via lymphatic absorption, and directly delivers target nutrients into systemic circulation with clinical efficiency.
Key Takeaway: True liposomal formulation requires precise high-pressure microfluidization to establish double-layer phospholipid vesicles ranging strictly between 100nm and 200nm in diameter, ensuring thermodynamic stability and superior intestinal cellular endocytosis.
Our state-of-the-art facilities leverage non-GMO sunflower phosphatidylcholine complexes, avoiding low-grade soy emulsifiers. By strictly maintaining particle size distribution and verified zeta potential (-30mV to -50mV), our liposomal delivery systems resist physical aggregation, phase separation, and chemical degradation throughout their commercial shelf life.
Building a successful private label supplement brand requires strategic SKU selection backed by clinical relevance and consumer appeal. Our engineering team specializes in stabilizing notoriously difficult molecules inside high-efficiency liposomal vesicles. Below are our premier turnkey platforms available for private label manufacturing and custom contract formulation:
Hydrophilic antioxidants prone to oxidation. Encapsulated in sub-150nm vesicles for direct cellular assimilation, reaching serum levels comparable to intravenous administration.
Cellular longevity precursors stabilized against enzymatic cleavage in the gut, ensuring intact cellular transport across mucosal membranes via sublingual liquids or enteric capsules.
Highly hydrophobic actives with poor native solubility. Converted into crystal-free, micellar-liposomal dispersions exhibiting up to 27-fold higher bio-absorption than standard powders.
Eliminates stomach discomfort, metallic taste, and constipation associated with traditional iron salts by shielding elemental iron inside non-reactive lipid nanocarriers.
Synergistic matrix combining fat-soluble (A, D3, E, K2) and water-soluble (B-Complex, C) nutrients into a unified, stable single-dose liquid packet or gel format.
Micro-encapsulated spray-dried liposomal powders designed for direct capsule filling, stick packs, and functional beverage mixes with rapid water reconstitutability.
Procurement directors and B2B sourcing executives must navigate evolving technical standards and regulatory requirements. The liposomal supplement market is maturing rapidly, shifting away from generic liquid mixtures toward verified nanotechnology platform solutions. Key trends influencing global contract manufacturing include:
While liquid liposomal drops and sachets remain popular, international shipping costs, shelf-life sensitivity, and microbial risks have accelerated demand for dry liposomal powders. Using low-temperature spray-drying and matrix stabilization, we create free-flowing liposomal powders that maintain their vesicle integrity upon rehydration in the digestive tract. This enables brand owners to offer liposomal benefits in clean hard-shell capsule formats without requiring artificial preservatives or refrigerated storage.
Clean-label requirements dominate modern retail channels. Traditional soy lecithin poses allergen risks and is frequently derived from genetically modified crops. Our ODM manufacturing utilizes high-purity Sunflower Phosphatidylcholine (PC > 70%), providing non-GMO, allergen-free, and allergen-compliant formulations that meet strict US, European, and Asian regulatory standards.
The industry is cracking down on "liposomal washing"—a practice where manufacturers blend unesterified oil and water without forming true vesicles. Retailers like Amazon, Walmart, and specialty health chains now require analytical proof of liposomal integrity. Our laboratory issues a comprehensive Certificate of Analysis (CoA) with every production batch, detailing:
Advanced product development is shifting toward dual-active liposomal systems. By encapsulating complementary actives—such as Liposomal Vitamin D3 with K2, or Liposomal CoQ10 with PQQ—within the same lipid nanoparticle matrix, brands achieve dual-action therapeutic synergy with optimized bioavailability and enhanced customer retention.
Partnering with our contract development and manufacturing organization gives your brand access to an agile, fully compliant, and scalable production infrastructure. Operating under strict regulatory oversight, our facility guarantees batch-to-batch consistency and complete chain-of-custody security.
Engineered under 21 CFR Part 111 (Dietary Supplements) and 21 CFR Part 117 (Preventive Controls for Human Food) with SQF Edition 9 certification.
Proprietary continuous-flow high-pressure homogenizers create stable, uniform lipid vesicles without thermal damage to delicate botanicals or vitamins.
Integrated manufacturing hub located in Springville, Utah (USA), complemented by EU-GMP infrastructure in the Netherlands and high-capacity processing facilities in Asia.
From initial benchtop formulation, flavoring development, and stability testing to automated filling and packaging—we deliver shelf-ready products in under 12 weeks.
Accessible production minimums starting at 6,000 units for liquid sachets/bottles and 5,000 units for capsules/tablets, scaling to high-volume multi-container runs.
Every batch includes a complete analytical dossier: CoAs, master batch records, stability testing reports, allergen declarations, and non-GMO affidavits.
Accelerate your product launch with pharmaceutical-grade nano-encapsulation, custom formulation support, and guaranteed 90-day turn-key execution.
